Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Augments Sphincter Bursting and Bladder Afferent Activity to Enhance Storage Function and Voiding Efficiency in Mice

BJU International - United Kingdom
doi 10.1111/bju.14664
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Wiley

Related search

Sildenafil and Phosphodiesterase-5 Inhibitors to Reduce Cardiotoxicity and Enhance the Response of Breast Tumors to Doxorubicin

2007English

Cancer Therapy Combination: Green Tea and a Phosphodiesterase 5 Inhibitor?

Journal of Clinical Investigation
Medicine
2013English

Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All-Cause Mortality

Heart
Cardiovascular MedicineCardiology
2016English

Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All Cause Mortality

Artery Research
2014English

Phosphodiesterase Type 5 Inhibitors: A Biochemical and Clinical Correlation Survey

International Journal of Impotence Research
Urology
2003English

Phosphodiesterase 5 Associates With Β2 Adrenergic Receptor to Modulate Cardiac Function in Type 2 Diabetic Hearts

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2019English

Cardiovascular Effects of Sildenafil in Hypertensive Men With Erectile Dysfunction and Different Alleles of the Type 5 cGMP-specific Phosphodiesterase (PDE5)

International Journal of Impotence Research
Urology
2004English

Preserved Adrenal Function After Lumbar Spinal Cord Transection Augments Low Pressure Bladder Activity in the Rat

Frontiers in Physiology
Physiology
2018English

Central Effect of Bladder Filling and Voiding.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1976English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy